|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1997-7-14
|
|
pubmed:abstractText |
Somatostatin receptor scintigraphy (SRS) has been used for the detection of gastroenteropancreatic (GEP) tumors. This study evaluates the clinical impact of SRS in GEP tumor detection and its therapeutic implications on patient management.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
38
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
853-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9189129-Carcinoid Tumor,
pubmed-meshheading:9189129-Case-Control Studies,
pubmed-meshheading:9189129-Diagnostic Imaging,
pubmed-meshheading:9189129-Female,
pubmed-meshheading:9189129-Gastrointestinal Neoplasms,
pubmed-meshheading:9189129-Humans,
pubmed-meshheading:9189129-Indium Radioisotopes,
pubmed-meshheading:9189129-Liver Neoplasms,
pubmed-meshheading:9189129-Lymphatic Metastasis,
pubmed-meshheading:9189129-Male,
pubmed-meshheading:9189129-Middle Aged,
pubmed-meshheading:9189129-Neuroendocrine Tumors,
pubmed-meshheading:9189129-Pancreatic Neoplasms,
pubmed-meshheading:9189129-Prospective Studies,
pubmed-meshheading:9189129-Receptors, Somatostatin,
pubmed-meshheading:9189129-Sensitivity and Specificity,
pubmed-meshheading:9189129-Somatostatin,
pubmed-meshheading:9189129-Tomography, Emission-Computed, Single-Photon,
pubmed-meshheading:9189129-Zollinger-Ellison Syndrome
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Clinical impact of somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors.
|
|
pubmed:affiliation |
Department of Nuclear medicine, Hôpital Bichat, Paris, France.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study
|
